Network Pharmacology Analysis, Molecular Docking, and In Vitro Verification Reveal the Action Mechanism of Prunella vulgaris L. in Treating Breast Cancer

被引:4
|
作者
Bai, Haotian [1 ]
Wang, Rui [1 ,2 ]
Li, Yalan [1 ]
Liang, Xiao [1 ]
Zhang, Junhao [1 ]
Sun, Na [3 ]
Yang, Jing [3 ]
机构
[1] Heilongjiang Univ Chinese Med, Coll Pharm, Harbin 150040, Heilongjiang, Peoples R China
[2] Heilongjiang Univ Chinese Med, Key Lab Basic & Applicat Res Beiyao, Minist Educ, Harbin 150040, Heilongjiang, Peoples R China
[3] Heilongjiang Univ Chinese Med, Coll Basic Med Sci, Harbin 150040, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
MICROTUBULE-ASSOCIATED PROTEIN-2; MESSENGER-RNA EXPRESSION; SIGNALING PATHWAY; INHIBITION; GROWTH; ERBB3; TARGET; TOP2A; METASTASIS; ACTIVATION;
D O I
10.1155/2022/5481563
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background. Prunella vulgaris L. is effective in the treatment of breast cancer (BRCA); however, the underlying mechanism is still unclear. The aim of this study was to elucidate the mechanism of treatment of BRCA by P. vulgaris using network pharmacology and molecular docking technology, and to verify the experimental results using human BRCA MDA-MB-231 cells. Methods. Active components and action targets of P. vulgaris were determined using the TCMSP (TM), SwissTarget Prediction (TM), and TargetNet (TM) databases. GeneCards (TM) and OMIM (TM) provided BRCA targets. After obtaining common targets, a protein-protein interaction (PPI) network was constructed using the STRING (TM) database, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted using the Xiantao (TM) academic database. Cytoscape (TM) was used to construct "single drug-disease-component-target" and "single drug-disease-component-target-pathway" networks. The Human Protein Atlas (TM) was used to determine protein expression levels in BRCA cell lines. AutoDock tools (TM) were used to carry out molecular docking for the first 10 targets of quercetin and the PPI network. Finally, the abovementioned results were verified using cell experiments. Results. We obtained 11 active components, 198 targets, and 179 common targets, including DUOX2, MET, TOP2A, and ERBB3. The results of KEGG pathway analysis screened 188 related signaling pathways and indicated the potential key role of PI3K-Akt and MAPK signaling pathways in the antibreast cancer process of P. vulgaris. The results of molecular docking showed that the first 10 targets of quercetin interacted well with the protein network. Cell experiments showed that quercetin effectively inhibited the proliferation of MDA-MB-231 cells by regulating apoptosis and cell cycle, which may be partly related to the MAPK signaling pathway. Conclusion. Synergistic effects of multiple components, targets, and pathways on the anti-BRCA activity of P. vulgaris could provide a theoretical basis for further study on its complex anti-BRCA mechanism.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Network pharmacology based virtual screening of active constituents of Prunella vulgaris L. and the molecular mechanism against breast cancer
    Zhang, Xiaobo
    Shen, Tao
    Zhou, Xin
    Tang, Xuehua
    Gao, Rui
    Xu, Lu
    Wang, Long
    Zhou, Zubin
    Lin, Jingjing
    Hu, Yuanzhang
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] Network pharmacology based virtual screening of active constituents of Prunella vulgaris L. and the molecular mechanism against breast cancer
    Xiaobo Zhang
    Tao Shen
    Xin Zhou
    Xuehua Tang
    Rui Gao
    Lu Xu
    Long Wang
    Zubin Zhou
    Jingjing Lin
    Yuanzhang Hu
    Scientific Reports, 10
  • [3] Network pharmacology and molecular docking to reveal the pharmacological mechanisms of Abelmoschus esculentus (l.) moench in treating breast cancer
    Ifeanyi Edozie Otuokere
    Julian Ibeji Iheanyichukwu
    Onuchi Marygem Mac-kalunta
    Chinedum Ifeanyi Nwankwo
    Comfort Michael Ngwu
    Stella Mbanyeaku Ufearoh
    Brendan Chidozie Asogwa
    Henry Chibueze Osiagor
    Felix Chigozie Nwadire
    In Silico Pharmacology, 13 (1)
  • [4] Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer
    Zhang, Zhiqiang
    Zhou, Jiayi
    Guo, Ruiqian
    Zhou, Qijun
    Wang, Lianzhi
    Xiang, Xingyan
    Ge, Sitong
    Cui, Zhezhu
    MEDICINE, 2023, 102 (45) : E34871
  • [5] Network Pharmacology to Explore the Mechanism of Prunella vulgaris L. Against Prolactinoma
    Meng, Jun-Hua
    Ni, Ping
    Cao, Yu-Ling
    Zhang, Yu
    Wang, Xiong
    Zhang, Hong
    Chen, Yong-Gang
    PHARMACOGNOSY MAGAZINE, 2024, 20 (01) : 127 - 136
  • [6] Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology
    Tu, Huahua
    Feng, Yanqing
    Wang, Wei
    Zhou, Huadong
    Cai, Qinghe
    Feng, Yong
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (01)
  • [7] Network pharmacology combined with molecular docking simulations reveal the mechanism of action of Glycyrrhiza for treating pneumonia
    Yang, Dongxin
    Li, Zhehong
    Peng, Yongrui
    Zhu, Xiaofeng
    Gong, Jun
    Chen, Cuilian
    PEPTIDE SCIENCE, 2024, 116 (03)
  • [8] Network pharmacology, molecular docking, and in vitro experimental verification of the mechanism of Guanxining in treating diabetic atherosclerosis
    Wang, Wenting
    Wang, Sutong
    Li, Yiwen
    Zhu, Mengmeng
    Xu, Qian
    Luo, Binyu
    Liu, Yanfei
    Liu, Yue
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 324
  • [9] Investigation of the mechanism of Prunella vulgaris in treatment of papillary thyroid carcinoma based on network pharmacology integrated molecular docking and experimental verification
    Zhu, Xiling
    Li, Yan
    Wang, Xiaodong
    Huang, Yuanshe
    Mao, Jingxin
    MEDICINE, 2023, 102 (17) : E33360
  • [10] Study on the Mechanism of Prunella Vulgaris L on Diabetes Mellitus Complicated with Hypertension Based on Network Pharmacology and Molecular Docking Analyses
    Jiao, Xinyi
    Liu, Haiying
    Lu, Qinan
    Wang, Yu
    Zhao, Yue
    Liu, Xuemei
    Liu, Fang
    Zuo, Yaoyao
    Wang, Wenbo
    Li, Yujie
    JOURNAL OF DIABETES RESEARCH, 2021, 2021